SIDNEY RAETZ
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family ROCKPORT, IN NPI 1124689633
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family IN Amgen Inc. All categories
General Payments — all program years on this page
$611.06
- Category: General Payments
- Program years: PY2021–2024
- Record count: 43
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $97.47 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $97.47 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $29.04 | 2 |
| Axsome Therapeutics, Inc. | $15.19 | 1 |
| Lilly USA, LLC | $13.55 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $13.29 | 1 |
| Phathom Pharmaceuticals, Inc. | $13.25 | 1 |
| Acerta Pharma LLC | $13.15 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1087199521 | Novartis Pharmaceuticals Corporation | $13.29 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104625720 | AstraZeneca Pharmaceuticals LP | $13.15 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117661151 | Amgen Inc. | $14.42 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117661153 | Amgen Inc. | $14.62 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135950056 | Lilly USA, LLC | $13.55 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1148410442 | Axsome Therapeutics, Inc. | $15.19 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1151198743 | Phathom Pharmaceuticals, Inc. | $13.25 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.